KNSA — KINIKSA PHARMACEUTICALS INTL

Ownership history in RICE HALL JAMES & ASSOCIATES, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which RICE HALL JAMES & ASSOCIATES, LLC reported a position in KINIKSA PHARMACEUTICALS INTL (KNSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.35% (2025 Q4)
Avg. % of fund
0.94%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 596,431 +18,609 +3.2% 1.35% $24.6M $41.25
2025 Q3 REDUCED 577,822 -60,411 -9.5% 1.22% $22.4M $38.83
2025 Q2 ADDED 638,233 +13,688 +2.2% 0.95% $17.7M $27.67
2025 Q1 REDUCED 624,545 -18,207 -2.8% 0.82% $13.9M $22.21
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KNSA price (monthly, adj. close)

Other funds also holding KNSA

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.6% Fairmount Funds Management LLC 3Y 4.14% Parkman Healthcare Partners LLC 3Y 2.61% Rubric Capital Management LP 3Y 7Y 1.64% ESSEX INVESTMENT MANAGEMENT CO LLC 3Y 7Y 1.58% Soleus Capital Management, L.P. 3Y 0.89% Logos Global Management LP 3Y 0.87% BAKER BROS. ADVISORS LP 3Y 7Y 0.68% GLOBEFLEX CAPITAL L P 3Y 7Y 0.59% Granahan Investment Management, LLC 3Y 7Y 0.56%
← Back to RICE HALL JAMES & ASSOCIATES, LLC Holdings